PreprintAll rights reservedmedRxiv
Fibrinolysis resistance in sepsis assessed by serial beside viscoelastometry is associated with plasma protein profiles and organ-failure severity: a prospective observational study
- 1Intensive Care Unit, Liverpool Hospital, Liverpool, Australia
Related
- Modelled mortality benefits of reducing fibrinolysis resistance in sepsis: integrating observational and ex vivo data
- Incidence and Progression of Acute Kidney Injury Following Head and Neck Surgeries for COVID-19-Associated Mucormycosis: A Prospective Observational Study
- Dynamic Changes in Serum Neutrophil Gelatinase-Associated Lipocalin for Discrimination of Creatinine-Defined Acute Kidney Injury After Laparoscopic Sleeve Gastrectomy: A Prospective Observational Cohort Study
- Smaller-diameter operative hysteroscopy is associated with fewer intraoperative complications without compromising efficiency: a prospective observational study
- Sublingual High-Velocity Blood Flow at Hospital Admission is Associated with Incident Sepsis Within 48 Hours in Patients with Suspected Infection: A Prospective Observational Study
BibTeX
@misc{coupland2026fibrinolysis,
title = {{Fibrinolysis resistance in sepsis assessed by serial beside viscoelastometry is associated with plasma protein profiles and organ-failure severity: a prospective observational study}},
author = {L. Coupland and M. Self and E. Suryana and R. Law and P. Crispin and R. Medcalf and C. Keragala and S. Frost and D. Rabbolini and P. Moore and A. Aneman},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.24.26366401},
url = {https://www.medrxiv.org/content/10.64898/2026.10.24.26366401v1},
}
RIS
TY - UNPB
TI - Fibrinolysis resistance in sepsis assessed by serial beside viscoelastometry is associated with plasma protein profiles and organ-failure severity: a prospective observational study
AU - L. Coupland
AU - M. Self
AU - E. Suryana
AU - R. Law
AU - P. Crispin
AU - R. Medcalf
AU - C. Keragala
AU - S. Frost
AU - D. Rabbolini
AU - P. Moore
AU - A. Aneman
PY - 2026
DA - 2026/10/24
PB - medRxiv
DO - 10.64898/2026.10.24.26366401
UR - https://www.medrxiv.org/content/10.64898/2026.10.24.26366401v1
ER -